Brief: Sinomab Bioscience To Sell Units Of Class A Participating Shares In China Healthcare Fund
04/02/2021 14:12
Feb 4 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* TO SELL 775,347.912 UNITS OF CLASS A PARTICIPATING SHARES
IN
CHINA HEALTHCARE FUND FOR HK$110.6 MILLION
* SEES UNAUDITED GAIN OF ABOUT HK$32.6 MILLION FROM
DISPOSAL
* DISPOSAL WILL RESULT IN UNAUDITED GAIN OF ABOUT HK$32.6
MILLION
Source text for Eikon: ID:nHKS76Fbm9
Further company coverage: 3681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience